The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Tigecycline is a last-resort antibiotic for multidrug-resistant Acinetobacter baumannii infections.
• Rapid development of tigecycline resistance limits its clinical utility.

Purpose of the Study:

• To investigate the genetic mechanisms underlying tigecycline resistance in Acinetobacter baumannii.
• To understand the cellular response to tigecycline treatment.

Main Methods:

• RNA sequencing was employed to analyze global gene expression changes in response to tigecycline.
• Quantification of (p)ppGpp levels was performed.

Main Results:

• Tigecycline treatment significantly reduced (p)ppGpp levels, impacting stringent response.
• Reduced (p)ppGpp led to altered ribosome production/degradation and decreased DNA repair efficiency.
• Upregulation of genes involved in horizontal gene transfer and RNA repair (rtcB) was observed.
• Downregulation of beta-lactamases and genes related to peptidoglycan biosynthesis occurred.

Conclusions:

• Tigecycline resistance in A. baumannii is multifactorial, involving altered ribosome homeostasis and DNA repair.
• Reduced (p)ppGpp is a key mediator of the cellular response to tigecycline, promoting resistance.
• Transcriptomic insights reveal pathways contributing to rapid resistance development.